| Ad Title: |
Gestational Trophoblastic Tumor |
| Study Title: |
A Phase II Trial of Pemetrexed (Alimta, Ly231514, Ind # 40061) in the Treatment of Recurrent Or Persistent Low Risk Gestational Trophoblastic Tumor |
| Protocol Number: |
052006-017 |
| Department(s) involved in the Study: |
Gynecology, Obstetrics & Gynecology, Simmons Comprehensive Cancer Center
|
| Purpose of the Study: |
To find out what effects, good and/or bad the drug Pemetrexed has on the patient and gestational trophoblastic tumors. |
| Participant Eligibility: |
Call Study Coordinator for eligibilty. |
| Disease/Condition Under Study: |
Gestational Trophoblastic Tumors |
| Cancer Related Study: |
Yes
|
| Study Drug(s): |
Alimta (Pemetrexed)
|
| Study Device(s): |
|
| Study Doctor: |
Dr. David Miller |
| Location of Study: |
|
Sites
|
Recruiting at this Site
|
|
Parkland Memorial Hospital
|
Yes
|
|
University of Texas Southwestern Medical Center
|
Yes
|
|
| Contact Phone: |
214_648_86753 |
| Email: |
Paula.Honea@utsouthwestern.edu |
| Other Information: |
This is a Gynecologic Oncology Group sponsored trial. |
| Website Keywords: |
Gyn Oncology, Gynecology, Women's Health
|
| Medical Keywords: |
Cancer
|
